Evidence map›Paper›PMID 25829000›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2015

Transmission of Mycobacterium tuberculosis in China: a population-based molecular epidemiologic study.

Chongguang Yang, Xin Shen, Ying Peng, Rushu Lan, Yuling Zhao, Bo Long, Tao Luo, Guomei Sun, Xia Li, Ke Qiao and 11 more

Open access · bronzeAbstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed, 1 pooled it
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 1 synthesis or guideline pooled it, 90 citations in OpenAlex.

  1. Pooled it
  2. First Insight into the Molecular Epidemiology ofBioMed research international · 2017
    Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Sentinel-Site-Based Surveillance ofAntibiotics (Basel, Switzerland) · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Drug-Resistant Profiles and Genetic Diversity ofInfection and drug resistance · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors at 8 institutions in 3 countries.

Chongguang YangKey Laboratory of Medical Molecular Virology of Ministries of Education and Health, Institutes of Biomedical Sciences and Institute of Medical Microbiology, Shanghai Medical College, Fudan University.
Xin ShenDepartment of Tuberculosis Control, Shanghai Municipal Center for Disease Control and Prevention.
Ying PengTuberculosis Control Center of Heilongjiang Province, Harbin.
Rushu LanGuangxi Zhuang Autonomous Region Center for Disease Control and Prevention, Nanning.
Yuling ZhaoHenan Center for Disease Control and Prevention, Zhengdong New District, Zhengzhou.
Bo LongSichuan Center for Disease Control and Prevention, Chengdu.
Tao LuoKey Laboratory of Medical Molecular Virology of Ministries of Education and Health, Institutes of Biomedical Sciences and Institute of Medical Microbiology, Shanghai Medical College, Fudan University.
Guomei SunKey Laboratory of Medical Molecular Virology of Ministries of Education and Health, Institutes of Biomedical Sciences and Institute of Medical Microbiology, Shanghai Medical College, Fudan University.
Xia LiKey Laboratory of Medical Molecular Virology of Ministries of Education and Health, Institutes of Biomedical Sciences and Institute of Medical Microbiology, Shanghai Medical College, Fudan University.
Ke QiaoKey Laboratory of Medical Molecular Virology of Ministries of Education and Health, Institutes of Biomedical Sciences and Institute of Medical Microbiology, Shanghai Medical College, Fudan University.
Xiaohong GuiDepartment of Tuberculosis Control, Shanghai Municipal Center for Disease Control and Prevention.
Jie WuDepartment of Tuberculosis Control, Shanghai Municipal Center for Disease Control and Prevention.
Jiying XuHenan Center for Disease Control and Prevention, Zhengdong New District, Zhengzhou.
Fabin LiTuberculosis Control Center of Heilongjiang Province, Harbin.
Dingyue LiSichuan Center for Disease Control and Prevention, Chengdu.
Feiying LiuGuangxi Zhuang Autonomous Region Center for Disease Control and Prevention, Nanning.
Mei ShenDepartment of Tuberculosis Control, Shanghai Municipal Center for Disease Control and Prevention.
Jianjun HongDepartment of Tuberculosis Control, Songjiang District Center for Disease Control and Prevention, Shanghai, People's Republic of China.
Jian MeiDepartment of Tuberculosis Control, Shanghai Municipal Center for Disease Control and Prevention.
Kathryn DeRiemerSchool of Medicine, University of California, Davis.
Qian GaoKey Laboratory of Medical Molecular Virology of Ministries of Education and Health, Institutes of Biomedical Sciences and Institute of Medical Microbiology, Shanghai Medical College, Fudan University.
Shanghai Medical College of Fudan University · CNCenter for Disease Control · TWHeilongjiang Center for Tuberculosis Control and Prevention · CNHenan Provincial Center for Disease Control and Prevention · CNSichuan Center for Disease Control and Prevention · CNGuangxi Center for Disease Prevention and Control · CNShanghai Municipal Center For Disease Control Prevention · CNUniversity of California, Davis · US

Funding

University of California Launching Future Leaders in Global Health Research Training ProgramD43TW009343 · FIC · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CRAIG R COHEN, Sung-Jae Lee · 2017 to 2026
$14.7M
University of California Global Health Institute Program for Fellows and ScholarsR25TW009343 · FIC · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI COHEN, CRAIG R, STRATHDEE, STEFFANIE A. · 2012 to 2017
$6.4M
Transmission and virulence of Mycobacterium tuberculosisDP2OD006452 · OD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI DERIEMER, KATHRYN L · 2010 to 2010
$2.3M
UC Davis-China Infectious Disease Research TrainingD43TW007887 · FIC · UNIVERSITY OF CALIFORNIA AT DAVIS · PI DERIEMER, KATHRYN L · 2008 to 2012
$743k
FIC NIH HHS D43 TW007887FIC NIH HHS D43TW007887FIC NIH HHS D43 TW009343FIC NIH HHS R25 TW009343FIC NIH HHS R25TW009343NIH HHS 1DP2 OD006452-01NIH HHS DP2 OD006452
6 · The paper itself

Abstract

backgroundUnderstanding the transmission of Mycobacterium tuberculosis is essential for the development of efficient tuberculosis control strategies. China has the second-largest tuberculosis burden in the world. Recent transmission and infection with M. tuberculosis, particularly drug-resistant strains, may account for many new tuberculosis cases.

methodsWe performed a population-based molecular epidemiologic study of pulmonary tuberculosis in China during 1 July 2009 to 30 June 2012. We defined clusters as cases with identical variable number tandem repeat genotype patterns and identified the risk factors associated with clustering, by logistic regression. Relative transmission rates were estimated by the sputum smear status and drug susceptibility status of tuberculosis patients.

resultsAmong 2274 culture-positive tuberculosis patients with genotyped isolates, there were 705 (31.0%) tuberculosis patients in 287 clusters. Multidrug-resistant (MDR) tuberculosis (adjusted odds ratio [aOR], 1.86; 95% confidence interval [CI], 1.25-2.63) and infection with a Beijing family strain (aOR, 1.56; 95% CI, 1.23-2.96) were associated with clustering. Eighty-four of 280 (30.0%) clusters had a putative source case that was sputum smear negative, and 30.6% of their secondary cases were attributed to transmission by sputum smear-negative patients. The relative transmission rate for sputum smear negative compared with sputum smear-positive patients was 0.89 (95% CI, .68-1.10), and was 1.51 (95% CI, 1.00-2.24) for MDR tuberculosis vs drug-susceptible tuberculosis.

conclusionsRecent transmission of M. tuberculosis, including MDR strains, contributes substantially to tuberculosis disease in China. Sputum smear-negative cases were responsible for at least 30% of the secondary cases. Interventions to reduce the transmission of M. tuberculosis should be implemented in China.

Indexed as

AdultAgedAntitubercular AgentsBeijingChinaCluster AnalysisDNA, BacterialFemaleGenotypeHumansMaleMicrobial Sensitivity TestsMiddle AgedMinisatellite RepeatsMolecular EpidemiologyMycobacterium tuberculosisAntitubercular AgentsDNA, BacterialChinamolecular epidemiologyrecent transmissiontuberculosis

Identifiers

PMID25829000
PMCPMC4490233
OpenAlexW2105359415

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.